A Phase 1 Investigator Initiated Trial of ONC-782 in China
Latest Information Update: 03 Oct 2024
At a glance
- Drugs ONC 782 (Primary)
- Indications Haematological malignancies; Solid tumours
- Focus Adverse reactions
- Sponsors OncoC4
- 03 Oct 2024 New trial record
- 25 Sep 2024 According to an OncoC4 media release, initiation of Phase 1 Investigator Initiated Trial in China expected in 2H 2024.